JAGSNPHARM Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > jagsnpharm

Technical Analysis

Technical Strength: 1 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 38.8. According to RSI analysis, jagsnpharm just got below it's support level and showing negative signal. 1.0 JAGSNPHARM RSI Chart
MACD (?) MACD: -0.0861 and Signal Line: 0.296. According to MACD analysis, jagsnpharm is technically weak. 2.0 JAGSNPHARM MACD Chart
Simple Moving Average (?) According to simple moving average analysis, jagsnpharm is in a downtrend. Resistance level is at 35.5. 1.0 JAGSNPHARM Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, jagsnpharm is in a downtrend. Resistance level is at 35.6. 1.0 JAGSNPHARM Exponential Moving Average Chart
Bollinger Bands (?) %b is -0.0568. According to bollinger bands, jagsnpharm has hit the lower band which is a negative signal. 1.0 JAGSNPHARM Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, no levels identified. NA JAGSNPHARM Fibonacci Retracement Chart
Average True Range (?) ATR: 1.99 NA JAGSNPHARM Average True Range Chart
Average Directional Index (?) ADX is 25.3 which means JAGSNPHARM is in a trend. NA JAGSNPHARM Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
December 14, 2017
Open Price 35.9
High Price 35.9
Low Price 33.5
Close Price 33.85
Absolute Change -0.7
Percentage Change -2.03%
Weekly Change -8.14%
Monthly Change -2.17%
Yearly Change -4.92%
52-week high 50.85
52-week low 28.0
Corporate Actions
ExDate Purpose
September 21, 2017 AGM/DIV-RE 0.10 PER SH
September 21, 2016 AGM/DIV-RE 0.10 PER SHARE
September 25, 2014 AGM/DIV-RE 0.50 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.955
Confidence in Beta2.12%
Market Capital Rs. 88.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 1.24
TTM Price-to-Earnings (P/E) Ratio 27.3
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 14 December 2017: Deliverable Quantity:2.29e+04 NA JAGSNPHARM Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 14 December 2017: Daily Volatility:0.6018 NA JAGSNPHARM Annualized Daily Volatility (Spot Price) Chart

Announcements

December 13, 2017 Committee Meeting Updates Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding Outcome of Committee Meeting held on December 12, 2017.
December 12, 2017 Outcome of Board Meeting Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on December 12, 2017.Sir/Madam,
See all Announcements

Board Meetings

Date Meeting Date Purpose
May 22, 2017 May 28, 2017 Results/Dividend Inter alia to consider and approve the Audited Financial Results of the Company for the year from April 1st, 2016 to March 31, 2017 and consider Dividend,
February 03, 2017 February 14, 2017 Results Inter alia to consider and approve the Un-audited Financial Results (provisional) of the Company for the third quarter and nine months ended December 31, 2016.
See all Board Meetings

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 30.53 Rs. 32.02 Rs. 32.93 Rs. 34.42 Rs. 35.33 Rs. 36.82 Rs. 37.73